Matthew Callahan

Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia.

Nemgenix Pty Ltd. develops new technologies for the control of plant parasitic nematodes and aphids. The company was founded by Sean Hird and Michael Jones in 2007 and is headquartered in Perth, Australia.

iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA.

Ben Franklin Technology Partners of Southeastern Pennsylvania engages in investment and advisory services. It provides capital to information technology, health, manufacturing, energy, and physical sciences industries. The company is headquartered in Philadelphia, PA.

Stone Ridge Ventures Pty Ltd (Stone Ridge Ventures) is a venture capital firm founded in 2002 by Matthew Callahan and Robert Melville Newman. The firm is headquartered in Balcatta, Australia.

Botanix Pharmaceuticals, Inc. develops therapeutics for the treatment of serious skin diseases. Its products include BTX1503-Acne, BTX1308-Plaque Psoriasis, and BTX1204-Atopic Dermatitis. The company is headquartered in Plymouth Meeting, PA.

Glycan Bioscience LLC develops carbohydrate-based drugs. The private company is based in New York. The American company was founded by Zoltan Kerekes.

Respirion Pharmaceuticals Pty Ltd. operates as a biotechnology firm. It focuses on development new treatments for respiratory diseases. The company was founded by Barry Clements in 2018 and is headquartered in Iluka, Australia.

Riverside Partners LLC /New York/ (Riverside Partners) is a private equity firm founded in 1988 by Bela Szigethy. The firm is headquartered in Boston, Massachusetts with additional offices across the globe.

Microsize LLC specializes in enhancing the dissolution and bioavailability of APIs through particle size reduction using micronization technologies. The company is based in Quakertown, PA. The company is the largest independent US-based company specializing in micronization and particle size control. The company has expertise in developing milling and micronization processes for a diverse range of API and excipient materials with unique physical property challenges. The company was founded in 1994. The CEO is TJ Higley.